Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.Virus Res. 2020 Sep; 286:198073.VR
Abstract
The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global pandemic. Up to now, numerous medicines have been applied or approved for the prevention and control of the virus infection. However, the efficiency of each medicine or combination is completely different or still unknown. In this review, we discuss the types, characteristics, antiviral mechanisms, and shortcomings of recommended candidate medicines for SARS-CoV-2 infection, as well as perspectives of the drugs for the disease treatment, which may provide a theoretical basis for drug screening and application.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Review
Language
eng
PubMed ID
32592817
Citation
Li, Chang, et al. "Antiviral Mechanisms of Candidate Chemical Medicines and Traditional Chinese Medicines for SARS-CoV-2 Infection." Virus Research, vol. 286, 2020, p. 198073.
Li C, Wang L, Ren L. Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection. Virus Res. 2020;286:198073.
Li, C., Wang, L., & Ren, L. (2020). Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection. Virus Research, 286, 198073. https://doi.org/10.1016/j.virusres.2020.198073
Li C, Wang L, Ren L. Antiviral Mechanisms of Candidate Chemical Medicines and Traditional Chinese Medicines for SARS-CoV-2 Infection. Virus Res. 2020;286:198073. PubMed PMID: 32592817.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.
AU - Li,Chang,
AU - Wang,Lin,
AU - Ren,Linzhu,
Y1 - 2020/06/24/
PY - 2020/5/2/received
PY - 2020/6/22/revised
PY - 2020/6/22/accepted
PY - 2020/6/28/pubmed
PY - 2020/9/9/medline
PY - 2020/6/28/entrez
KW - Antiviral
KW - Coronavirus disease 2019 (COVID-19)
KW - Medicine
KW - Severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus, SARS-CoV-2)
SP - 198073
EP - 198073
JF - Virus research
JO - Virus Res
VL - 286
N2 - The Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a global pandemic. Up to now, numerous medicines have been applied or approved for the prevention and control of the virus infection. However, the efficiency of each medicine or combination is completely different or still unknown. In this review, we discuss the types, characteristics, antiviral mechanisms, and shortcomings of recommended candidate medicines for SARS-CoV-2 infection, as well as perspectives of the drugs for the disease treatment, which may provide a theoretical basis for drug screening and application.
SN - 1872-7492
UR - https://www.unboundmedicine.com/medline/citation/32592817/Antiviral_mechanisms_of_candidate_chemical_medicines_and_traditional_Chinese_medicines_for_SARS_CoV_2_infection_
DB - PRIME
DP - Unbound Medicine
ER -